Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview (2023)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; FAVARO, MARIANNA TEIXEIRA DE PINHO - ICB
- Unidade: ICB
- DOI: 10.3390/pharmaceutics15041197
- Subjects: MICROBIOLOGIA; PROTEÍNAS; PROTEÍNAS RECOMBINANTES; MEDICAMENTO; NANOPARTÍCULAS; AMINOÁCIDOS; POLIPEPTÍDEOS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 15, n. 4, art. 1197, p. 1-16, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CORCHERO, José Luis et al. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041197. Acesso em: 02 out. 2024. -
APA
Corchero, J. L., Favaro, M. T. P., Márquez-Martínez, M., Lascorz, J., Martínez-Torró, C., Sánchez, J. M., et al. (2023). Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, 15( 4), 1-16. doi:10.3390/pharmaceutics15041197 -
NLM
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2024 out. 02 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 -
Vancouver
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2024 out. 02 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 - Avaliação das propriedades imunológicas e papel vacinal da flagelina fliCi de Salmonella enterica pv Typhimurium
- Expression of enterotoxigenic Escherichia coli proteins by genetically modified Bacillus subtilis strains as a new approach to develop mucosal vaccines
- Immunogenicity of flagelins FliCi e FliCd following oral immunization of mice with attenuated salmonella strains
- Evaluation of the genetic diversity among enterotoxigenic Escherichia coli (ETEC) strains isolated from humans in Brazil and Argentina
- Construção de uma vacina de DNA bivalente contra os vírus do papiloma e herpes simplex humano
- A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 'A ind.2' and B subunits confers protective immunity to shiga toxin challenge in the murine model
- Produção e purificação da flagelina FliCi de S. Typhimurium
- Surface expression of adhesins enhances the vaccine potential of orally delivered Bacillus subtilis strains
- Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human Papillomavirus type 16 oncoproteins genetically fused to Herpesvirus glycoprotein D
- Characterization of a DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the N-terminal domain of Salmonella enterica SV Müenchen FLICd flagellin
Informações sobre o DOI: 10.3390/pharmaceutics15041197 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas